These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
124 related articles for article (PubMed ID: 30942396)
1. lncRNA AWPPH promotes proliferation and inhibits apoptosis of non‑small cell lung cancer cells by activating the Wnt/β‑catenin signaling pathway. Song Z; Du J; Zhou L; Sun B Mol Med Rep; 2019 May; 19(5):4425-4432. PubMed ID: 30942396 [TBL] [Abstract][Full Text] [Related]
2. LncRNA AWPPH promotes the proliferation, migration and invasion of ovarian carcinoma cells via activation of the Wnt/β‑catenin signaling pathway. Yu G; Wang W; Deng J; Dong S Mol Med Rep; 2019 May; 19(5):3615-3621. PubMed ID: 30896797 [TBL] [Abstract][Full Text] [Related]
3. Long Non-Coding RNA AWPPH Promotes Postoperative Distant Recurrence in Resected Non-Small Cell Lung Cancer by Upregulating Transforming Growth Factor beta 1 (TGF-β1). Tang L; Wang T; Zhang Y; Zhang J; Zhao H; Wang H; Wu Y; Liu K Med Sci Monit; 2019 Apr; 25():2535-2541. PubMed ID: 30953582 [TBL] [Abstract][Full Text] [Related]
4. IL‑21/IL‑21R inhibit tumor growth and invasion in non‑small cell lung cancer cells via suppressing Wnt/β‑catenin signaling and PD‑L1 expression. Xue D; Yang P; Wei Q; Li X; Lin L; Lin T Int J Mol Med; 2019 Nov; 44(5):1697-1706. PubMed ID: 31573051 [TBL] [Abstract][Full Text] [Related]
5. LncRNA HULC promotes non-small cell lung cancer cell proliferation and inhibits the apoptosis by up-regulating sphingosine kinase 1 (SPHK1) and its downstream PI3K/Akt pathway. Liu L; Zhou XY; Zhang JQ; Wang GG; He J; Chen YY; Huang C; Li L; Li SQ Eur Rev Med Pharmacol Sci; 2018 Dec; 22(24):8722-8730. PubMed ID: 30575912 [TBL] [Abstract][Full Text] [Related]
6. LncRNA AWPPH accelerates the progression of non-small cell lung cancer by sponging miRNA-204 to upregulate CDK6. Wu D; Qin BY; Qi XG; Hong LL; Zhong HB; Huang JY Eur Rev Med Pharmacol Sci; 2020 Apr; 24(8):4281-4287. PubMed ID: 32373964 [TBL] [Abstract][Full Text] [Related]
7. Nucleolar and spindle‑associated protein 1 promotes non‑small cell lung cancer progression and serves as an effector of myocyte enhancer factor 2D. Ling B; Wei P; Xiao J; Cen B; Wei H; Feng X; Ye G; Li S; Zhang Z; Liang W; Huang S; Huang W Oncol Rep; 2021 Mar; 45(3):1044-1058. PubMed ID: 33650655 [TBL] [Abstract][Full Text] [Related]
8. Upregulated lncRNA SNHG1 contributes to progression of non-small cell lung cancer through inhibition of miR-101-3p and activation of Wnt/β-catenin signaling pathway. Cui Y; Zhang F; Zhu C; Geng L; Tian T; Liu H Oncotarget; 2017 Mar; 8(11):17785-17794. PubMed ID: 28147312 [TBL] [Abstract][Full Text] [Related]
9. LncRNA AWPPH promotes osteosarcoma progression via activation of Wnt/β-catenin pathway through modulating miR-93-3p/FZD7 axis. Li C; Wang F; Wei B; Wang L; Kong D Biochem Biophys Res Commun; 2019 Jun; 514(3):1017-1022. PubMed ID: 31092328 [TBL] [Abstract][Full Text] [Related]
10. Long noncoding RNA AWPPH promotes hepatocellular carcinoma progression through YBX1 and serves as a prognostic biomarker. Zhao X; Liu Y; Yu S Biochim Biophys Acta Mol Basis Dis; 2017 Jul; 1863(7):1805-1816. PubMed ID: 28428004 [TBL] [Abstract][Full Text] [Related]
11. Wnt inhibitory factor-1-mediated autophagy inhibits Wnt/β-catenin signaling by downregulating dishevelled-2 expression in non-small cell lung cancer cells. Luo X; Ye S; Jiang Q; Gong Y; Yuan Y; Hu X; Su X; Zhu W Int J Oncol; 2018 Aug; 53(2):904-914. PubMed ID: 29916529 [TBL] [Abstract][Full Text] [Related]
12. LncRNA AWPPH and miRNA-21 regulates cancer cell proliferation and chemosensitivity in triple-negative breast cancer by interacting with each other. Liu AN; Qu HJ; Gong WJ; Xiang JY; Yang MM; Zhang W J Cell Biochem; 2019 Sep; 120(9):14860-14866. PubMed ID: 31033015 [TBL] [Abstract][Full Text] [Related]
13. Long noncoding RNA XIST acts as an oncogene in non-small cell lung cancer by epigenetically repressing KLF2 expression. Fang J; Sun CC; Gong C Biochem Biophys Res Commun; 2016 Sep; 478(2):811-7. PubMed ID: 27501756 [TBL] [Abstract][Full Text] [Related]
14. Upregulation of long non‑coding RNA CCEPR is associated with poor prognosis and contributes to the progression of ovarian cancer through regulating the Wnt/β‑catenin signaling pathway. Chen Z; Zhu Y; Fan X; Liu Y; Feng Q Mol Med Rep; 2020 Apr; 21(4):1950-1958. PubMed ID: 32319633 [TBL] [Abstract][Full Text] [Related]
15. LncRNA AWPPH promotes the growth of triple-negative breast cancer by up-regulating frizzled homolog 7 (FZD7). Wang K; Li X; Song C; Li M Biosci Rep; 2018 Dec; 38(6):. PubMed ID: 30333256 [No Abstract] [Full Text] [Related]
16. Highly expressed lncRNA LOC730101 promotes lung cancer cell growth through Wnt canonical pathway. Liu L; Zhang Y; Cao W Biochem Biophys Res Commun; 2017 Nov; 493(2):992-997. PubMed ID: 28943432 [TBL] [Abstract][Full Text] [Related]
17. LncRNA GASL1 inhibits tumor growth of non-small cell lung cancer by inactivating TGF-β pathway. Su WZ; Yuan X Eur Rev Med Pharmacol Sci; 2018 Nov; 22(21):7282-7288. PubMed ID: 30468472 [TBL] [Abstract][Full Text] [Related]
18. Increased expression of the lncRNA PVT1 promotes tumorigenesis in non-small cell lung cancer. Yang YR; Zang SZ; Zhong CL; Li YX; Zhao SS; Feng XJ Int J Clin Exp Pathol; 2014; 7(10):6929-35. PubMed ID: 25400777 [TBL] [Abstract][Full Text] [Related]
19. Downregulation of Meg3 enhances cisplatin resistance of lung cancer cells through activation of the WNT/β-catenin signaling pathway. Xia Y; He Z; Liu B; Wang P; Chen Y Mol Med Rep; 2015 Sep; 12(3):4530-4537. PubMed ID: 26059239 [TBL] [Abstract][Full Text] [Related]
20. Long non-coding RNA NEAT1 acts as oncogene in NSCLC by regulating the Wnt signaling pathway. Sun SJ; Lin Q; Ma JX; Shi WW; Yang B; Li F Eur Rev Med Pharmacol Sci; 2017 Feb; 21(3):504-510. PubMed ID: 28239820 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]